A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer. (6th November 2014) - Fuller, Steven; Lebowitz, Michael S; Stewart, Solomon; Ghanbari, Hossein A